Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Chrisofos

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Clinical Genitourinary Cancer|May 14, 2014
Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional studyAristotle Bamias, Kimon Tzannis, Athanasios Papatsoris, et al.
BMC Infectious Diseases|November 5, 2011
TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogenThekla Poukoulidou, Aikaterini Spyridaki, Ira Mihailidou, et al.
Cancer Management and Research|August 6, 2021
Referral for "Neoadjuvant Chemotherapy" for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and OutcomesAthanasios Dellis, Roubini Zakopoulou, Andromahi Kougioumtzopoulou, et al.
Cancer Medicine|March 24, 2016
Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysisAristotle Bamias, Petros Tsantoulis, Thomas Zilli, et al.
Critical Reviews in Oncology/Hematology|August 30, 2008
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approachJohn M Fitzpatrick, John Anderson, Cora N Sternberg, et al.
Critical Care (London, England)|August 10, 2012
Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptorEvangelos J Giamarellos-Bourboulis, Anna Norrby-Teglund, Vassiliki Mylona, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Clinical Genitourinary Cancer|May 14, 2014
Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional studyAristotle Bamias, Kimon Tzannis, Athanasios Papatsoris, et al.
BMC Infectious Diseases|November 5, 2011
TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogenThekla Poukoulidou, Aikaterini Spyridaki, Ira Mihailidou, et al.
Cancer Management and Research|August 6, 2021
Referral for "Neoadjuvant Chemotherapy" for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and OutcomesAthanasios Dellis, Roubini Zakopoulou, Andromahi Kougioumtzopoulou, et al.
Cancer Medicine|March 24, 2016
Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysisAristotle Bamias, Petros Tsantoulis, Thomas Zilli, et al.
Critical Reviews in Oncology/Hematology|August 30, 2008
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approachJohn M Fitzpatrick, John Anderson, Cora N Sternberg, et al.
Critical Care (London, England)|August 10, 2012
Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptorEvangelos J Giamarellos-Bourboulis, Anna Norrby-Teglund, Vassiliki Mylona, et al.
Pageof 8